BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16142330)

  • 1. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
    Van den Neste E; Cardoen S; Offner F; Bontemps F
    Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
    Pettitt AR; Sherrington PD; Cawley JC
    Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines.
    Bastin-Coyette L; Cardoen S; Smal C; de Viron E; Arts A; Amsailale R; Van Den Neste E; Bontemps F
    Biochem Pharmacol; 2011 Mar; 81(5):586-93. PubMed ID: 21168391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
    Fabianowska-Majewska K; Wyczechowska D
    Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
    King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
    Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fludarabine in hematological malignancies.
    Montillo M; Ricci F; Tedeschi A
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1141-61. PubMed ID: 17020450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response.
    de Viron E; Knoops L; Connerotte T; Smal C; Michaux L; Saussoy P; Vannuffel P; Beert E; Vekemans MC; Hermans C; Bontemps F; Van Den Neste E
    Br J Haematol; 2009 Dec; 147(5):641-52. PubMed ID: 19764992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
    Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
    Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
    Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
    Yamauchi T; Nowak BJ; Keating MJ; Plunkett W
    Clin Cancer Res; 2001 Nov; 7(11):3580-9. PubMed ID: 11705880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
    Kohnke PL; Mactier S; Almazi JG; Crossett B; Christopherson RI
    J Proteome Res; 2012 Sep; 11(9):4436-48. PubMed ID: 22839105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
    Begleiter A; Verburg L; Ashique A; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
    Mactier S; Henrich S; Che Y; Kohnke PL; Christopherson RI
    J Proteome Res; 2011 Mar; 10(3):1030-42. PubMed ID: 21182289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
    Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
    Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
    Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
    Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.
    Starczewska E; Beyaert M; Michaux L; Vekemans MC; Saussoy P; Bol V; Arana Echarri A; Smal C; Van Den Neste E; Bontemps F
    Oncotarget; 2016 Jun; 7(25):38367-38379. PubMed ID: 27223263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia.
    Rogalinska M; Goralski P; Wozniak K; Bednarek JD; Blonski JZ; Robak T; Piekarski H; Hanausek M; Walaszek Z; Kilianska ZM
    Leuk Res; 2009 Feb; 33(2):308-14. PubMed ID: 18676014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes.
    Sandoval A; Consoli U; Plunkett W
    Clin Cancer Res; 1996 Oct; 2(10):1731-41. PubMed ID: 9816124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.